)
Joe Newcome
Joseph “Joe” Newcome is an experienced leader in the cell and gene therapy space, having spent more than 20 years specializing in microbiology, quality control, and rapid testing solutions. Joe is currently a Senior Director, Analytical Development at Minaris Advanced Therapies (formerly WuXi Advanced Therapies) and focuses on providing innovative solutions for cell and gene therapy manufacturing and testing. With a strong background in GMP-compliant environments and expertise in microbiological testing methods, Joe is dedicated to ensuring high standards of product safety and efficacy, contributing to the success of advanced therapeutic products. In addition to Minaris Advanced Therapies, Joe has held senior roles in Quality Control at Resilience and T-munity.